key: cord-0983725-zsy6ftki
authors: el‐Azhary, Rokea
title: Re: Chilblain‐like lesions on feet and hands during the COVID‐19 pandemic
date: 2020-05-08
journal: Int J Dermatol
DOI: 10.1111/ijd.14956
sha: f1c149a45d1630ecdcf4256db8cb452a0d00c6ca
doc_id: 983725
cord_uid: zsy6ftki

nan

The coronavirus disease 2019 (COVID-19) viral pandemic has continued to challenge scientists and physicians attempting to understand the breadth of clinical manifestations and potential severity. Not restricted to the respiratory tract, it appears to affect many organ systems other than the lungs. Dermatologists have been on the watch for skin manifestations. Early on, various skin eruptions were reported, but none were considered specific, and some represented a viral exanthema. Somewhat While the dermatologists are reporting this phenomenon, the physicians taking care of patients have also been challenged by the number of strokes and coagulopathies noted by many. [3] [4] [5] The vascular lesions clinically evident in the skin must be related to what is going on systemically. Could these changes also be an early sign of disease in some patients? We advise the physicians who are caring for COVID-19 patients to examine the hands and feet of their patients, and if at all possible, obtain a biopsy and a thrombophilia panel when needed.

More importantly in today's climate, if a patient presents with these lesions, they need to firstly be tested for COVID-19, as this might be a sign of initial viral infection but could also be post-infection or even represent prolonged infection or a carrier state. This is history in the making, only time will tell.

Chilblainlike lesions on feet and hands during the COVID-19 pandemic

Lupus anticoagulant is frequent in patients with Covid-19

Explanation for COVID-19 infection neurological damage and reactivations

EXPRESS: COVID-19 and stroke -a global World Stroke Organisation perspective

High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients